10/06/2021 | Press release | Archived content
SIGA's CEO, Dr. Phillip Gomez, and Garrett Ingram, President, CEO of Cipla Therapeutics, discuss the companies' recently announced collaboration to provide the U.S. government with solutions for its biothreat and public health needs, with a focus on tackling antimicrobial resistance
June 10, 2021